ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
59,936.45
-1.10%
S&P 500
5,035.69
-1.57%
Dow Jones
37,815.92
-1.49%
US Dollar vs Yen
157.867
0.09%
Brent Oil
85.555
-0.40%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NYSE
  6. Invitae Corporation (NVTA)

  7. Invitae Corporation (NVTA) ニュース

NVTA Invitae Corporation

0.0891
0.00 (0.00%)
2024年4月30日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Invitae Corporation NVTA NYSE 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
0.00 0.00% 0.0891 09:00:00
始値 安値 高値 終値 前日終値
0.0891 0.0891
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/3/0622:31EDGAR2Form 8-K - Current report
2024/2/0707:07EDGAR2Form 8-K - Current report
2024/1/3021:00PRNUSInvitae Partners with BridgeBio Pharma to Harness Genetic..
2024/1/3006:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/2506:34EDGAR2Form 8-K/A - Current report: [Amend]
2024/1/2221:05EDGAR2Form 8-K - Current report
2024/1/2221:00PRNUSInvitae Completes Sale of Reproductive Health Assets to..
2024/1/1906:10EDGAR2Form 8-K - Current report
2023/12/2211:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2211:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1506:29EDGAR2Form 8-K - Current report
2023/12/1406:07PRNUSInvitae Divests Ciitizen Health Data Platform and Implements..
2023/12/1206:41EDGAR2Form 8-K - Current report
2023/11/1806:48EDGAR2Form 8-K - Current report
2023/11/1606:22EDGAR2Form 8-K - Current report
2023/11/1509:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1509:55EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/11/0906:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0906:05EDGAR2Form 8-K - Current report
2023/11/0906:01PRNUSInvitae Reports Third Quarter 2023 Financial Results
2023/11/0706:00PRNUSInvitae Launches Enhanced Chemistry of MRD Test to Better..
2023/11/0119:59PRNUSInvitae to Announce Third Quarter 2023 Financial Results on..
2023/10/2600:00PRNUSLandmark Study Reveals Magnitude of Uncertain Results in..
2023/10/2107:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/2005:38EDGAR2Form 8-K - Current report
2023/10/2005:30PRNUSInvitae Appoints Dr. David Sholehvar as Chief Operating..
2023/10/1305:15PRNUSRural Hospital System Demonstrates the Clinical Benefits of..
2023/10/1105:30PRNUSInvitae to Present Data at the National Society of Genetic..
2023/10/0401:07PRNUSInvitae's Common Hereditary Cancers Panel Receives FDA..
2023/10/0310:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0309:47EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/9/3009:00DJNFDA Gives Marketing Authorization to Invitae Test for Cancer..
2023/9/2805:29EDGAR2Form 8-K - Current report
2023/9/2607:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2605:30PRNUSInvitae Announces Appointment of Finance Veteran Ana Schrank..
2023/9/2306:02EDGAR2Form 8-K - Current report
2023/9/2305:30PRNUSInvitae Receives Notice of Non-Compliance with NYSE Minimum..
2023/9/1506:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/8/2905:02PRNUSInvitae Hires Industry Veteran Robert Guigley as Chief..
2023/8/2321:12EDGAR2Form 8-K - Current report
2023/8/1520:30PRNUSClinical Trial Results Support Genetic Testing of All..
2023/8/1505:02PRNUSInvitae Announces Selection of Finance Executive Robert..
2023/8/1105:03EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
2023/8/1105:01EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
2023/8/1013:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/8/0922:22EDGAR2Form POS AM - Post-Effective amendments for registration..
2023/8/0922:20EDGAR2Form POS AM - Post-Effective amendments for registration..
2023/8/0905:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0905:09EDGAR2Form 8-K - Current report
2023/8/0905:01PRNUSInvitae Reports Second Quarter 2023 Financial Results

最近閲覧した銘柄

NYSE
NVTA
Invitae
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有